17.Aug.2010

OCT is launching in Russia a phase II clinical trial in 130 metastatic breast cancer patients.

OCT is launching in Russia a phase II clinical trial in 130 metastatic breast cancer patients.
OCT is launching in Russia a phase II clinical trial in 130 metastatic breast cancer patients.